Every AXIONOVA unit is catalogued inside one of ten functional systems. The taxonomy spans tissue repair, metabolic regulation, cellular renewal, growth-hormone signaling, neurocognitive function, immune defense, mitochondrial support, small-molecule modulation, endocrine regulation, and advanced weight-loss research.
The system framework gives practitioners a precise way to evaluate mechanism, protocol fit, pathway overlap, and monitoring requirements. Every system connects compound identity, dose format, documentation, and ALETHRA certification inside one governed structure.
AXIONOVA uses two distinct intelligence layers. ALETHRA is the active governance layer behind identity, verification, authorization, protocol compliance, chain-of-custody, cartridge records, and device event logs across compounds, AXIS, SENSE, and partner access. ALETHA is the active AXIONOVA AI agent for coaching, protocol personalization, diet programming, guided education, practitioner support, and 24/7 user assistance. Governance and intelligence operate together. ALETHRA governs the system. ALETHA guides the experience.
Tissue integrity, inflammatory balance, angiogenesis, and connective-tissue remodeling research.
The Repair / Recovery system focuses on tissue integrity, inflammatory balance, angiogenesis, and connective-tissue remodeling. Compounds in this class are evaluated for research involving fibroblast activity, soft-tissue recovery, gut-barrier context, skin repair, and post-stress structural support.





Lipolytic signaling, energy partitioning, hepatic fat metabolism, and insulin-pathway support.
The Metabolic / Body Composition system addresses lipolytic signaling, energy partitioning, hepatic fat metabolism, and insulin-pathway support. It is designed for research protocols focused on body-composition change, metabolic flexibility, and adipose-tissue signaling.


Cellular renewal, telomere biology, senescence research, and long-range healthspan signaling.
The Regenerative / Longevity system focuses on cellular renewal, telomere biology, senescence research, pineal-axis support, and long-range healthspan signaling. It is structured for protocols that require careful timing, cyclical use, and documented pathway rationale.



Endogenous GH pathway support, pulsatile release architecture, and IGF-1 signaling research.
The Signal / GH Axis system evaluates endogenous growth-hormone pathway support, pulsatile release architecture, IGF-1 context, and recovery signaling. It is positioned for practitioners studying signal-axis modulation rather than exogenous hormone replacement.





BDNF signaling, synaptic plasticity, memory consolidation, and adaptive neurological resilience.
The Neuro / Cognitive system focuses on BDNF signaling, synaptic plasticity, dopaminergic and serotonergic modulation, memory consolidation, attention, and adaptive neurological resilience. It supports structured research into cognitive performance and neuroplasticity.





T-cell activity, antimicrobial response, Th1 / Th2 balance, and macrophage activation research.
The Immune / Defense system addresses T-cell activity, antimicrobial response, Th1 / Th2 balance, macrophage activation, and immune-modulation research. It is designed for protocols requiring controlled review of immune signaling and inflammatory context.


Cardiolipin support, ATP production, mitochondrial biogenesis, and bioenergetic resilience.
The Mitochondrial / Cellular system focuses on cardiolipin support, ATP production, mitochondrial biogenesis, oxidative-stress reduction, and cellular energy context. It is used where protocol design depends on bioenergetic resilience and cellular efficiency.


Targeted enzyme and receptor-pathway research with oral bioavailability considerations.
The Small Molecule / Modulation system covers targeted enzyme and receptor-pathway research, including NNMT inhibition, ERR-alpha agonism, NAD+ pathway support, and oral bioavailability considerations. It gives practitioners a controlled category for small-molecule interventions.


HPG-axis signaling, kisspeptin activity, melanocortin activation, and endocrine architecture.
The Endocrine Regulation system focuses on HPG-axis signaling, kisspeptin activity, GnRH context, melanocortin activation, and LH / FSH pathway research. It is structured for protocols involving endocrine architecture and reproductive signaling.


Incretin signaling, glucagon receptor activity, appetite regulation, and visceral-fat research.
The Advanced Weight Loss system focuses on incretin signaling, glucagon receptor activity, appetite regulation, visceral-fat research, and body-composition protocols. It is designed for practitioner-supervised metabolic research under restricted access.


Start with a defined biological objective, review the relevant system, confirm compound identity, and proceed through practitioner access. AXIONOVA systems are built for structured research review, not consumer self-selection.